Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against Gram-positive cocci

被引：29
|
作者：
Coque, TM
Singh, KV
Murray, BE
机构：
[1] UNIV TEXAS,SCH MED,DIV INFECT DIS,DEPT INTERNAL MED,HOUSTON,TX 77030
[2] UNIV TEXAS,SCH MED,DEPT MICROBIOL & MOLEC GENET,HOUSTON,TX 77030
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1996年 / 37卷 / 05期
关键词：
D O I：
10.1093/jac/37.5.1011
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
The in-vitro activities of the new fluoroquinolone trovafloxacin (CP-99,219) and ciprofloxacin were determined against 225 Gram-positive cocci. Trovafloxacin was 4-32 fold more active than ciprofloxacin against staphylococci and streptococci and also showed greater activity against enterococci including vancomycin resistant Enterococcus faecium and Enterococcus faecalis that were highly resistant to aminoglycosides and/or produced beta-lactamase. Trovafloxacin was also bactericidal at 3 mg/L against enterococci except for isolates for which the MICs were greater than or equal to 2 mg/L.
引用
收藏
页码：1011 / 1016
页数：6
相关论文
共 50 条
  • [31] In vitro activity of linezolid against Gram-positive cocci isolated in Poland
    Szczypa, K
    Betlejewska, K
    Nowak, K
    Hryniewicz, K
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (06) : 932 - 934
  • [32] Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media
    Hecht, DW
    Osmolski, JR
    CLINICAL INFECTIOUS DISEASES, 1996, 23 : S44 - S50
  • [33] A study of in vitro activity of daptomycin against 2679 Gram-positive cocci
    张菲菲
    China Medical Abstracts(Internal Medicine), 2013, 30 (03) : 146 - 146
  • [34] In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci
    Tünger, A
    Aydemir, S
    Uluer, S
    Cilli, F
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2004, 120 (06) : 546 - 552
  • [35] Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci
    Tsao, Shih-Ming
    Lin, Hsiu-Chen
    Lee, Chun-Ming
    Hsu, Gwo-Jong
    Chen, Chih-Ming
    Sun, Wu
    Liu, Yung-Ching
    Jang, Tsrang-Neng
    Cheng, Yu-Jen
    Lu, Po-Liang
    Chiang, Ping-Chreng
    Wang, Lih-Shinn
    Kung, Hsiang-Chi
    Chuang, Yin-Ching
    Shi, Zhi-Yuan
    Liu, Jien-Wei
    Huang, Cheng-Hua
    Lu, Chin-Te
    Liao, Chun-Hsing
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 : S184 - S187
  • [36] Comparative In Vitro Activity of Trovafloxacin Against Gram-Positive and Gram-Negative Clinical Isolates from Argentina
    Adriana Sucari
    D. Stepanik
    J. M. Casellas
    G. Tomé
    L. Clara
    M. Marín
    A. Rossi
    M. Galas
    J. Smayevsky
    L. Dufranc
    H. Lorenzo
    L. de Vedia
    H. López
    Drugs, 1999, 58 : 195 - 199
  • [37] Comparative in vitro activity of trovafloxacin against Gram-positive and Gram-negative clinical isolates from Argentina
    Sucari, A
    Stepanik, D
    Casellas, JM
    Tomé, G
    Clara, L
    Marín, M
    Rossi, A
    Galas, M
    Smayevsky, J
    Dufranc, L
    Lorenzo, H
    de Vedia, L
    López, H
    DRUGS, 1999, 58 (Suppl 2) : 195 - 199
  • [38] IN-VITRO ACTIVITY OF CP-99,219, A NOVEL 7-(3-AZABICYCLO[3.1.0]HEXYL) NAPHTHYRIDONE ANTIMICROBIAL
    GOOTZ, TD
    BRIGHTY, KE
    ANDERSON, MR
    SCHMIEDER, BJ
    HASKELL, SL
    SUTCLIFFE, JA
    CASTALDI, MJ
    MCGUIRK, PR
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 19 (04) : 235 - 243
  • [39] Comparative in vitro activity of five macrolides against gram-positive cocci, Campylobacter species, and anaerobes
    Marina, M
    Ivanova, K
    Hadjieva, N
    Urumov, A
    EXPANDING INDICATIONS FOR THE NEW MACROLIDES, AZALIDES, AND STREPTOGRAMINS, 1997, 21 : 505 - 510
  • [40] IN-VITRO ANTIMICROBIAL ACTIVITY OF CP-99,219, A NOVEL AZABICYCLO-NAPHTHYRIDONE (VOL 37, PG 349, 1993)
    GOODING, BB
    JONES, RN
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) : 909 - 909
12345